Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 743-750

  Kurahashi, Kiyoyasu ^a   Kajikawa, Osamu ^b   Sawa, Teiji ^a   Ohara, Maria ^a   Gropper, Michael A ^a,c   Frank, Dara W ^d   Martin, Thomas R ^b   Wiener Kronish, Jeanine P ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; IODINE 125; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOTOXICITY; ISOTOPE LABELING; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SEPTIC SHOCK;

EID: 0032699215     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7124     Document Type: Article

References (37)

1. Fagon, J.Y., et al. 1993. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 94:281-288.
2. Rouby, J.J. 1996. Nosocomial infection in the critically ill. The lung as a target organ. Anesthesiology. 84:757-758.
3. Rouby, J.J. 1996. Histology and microbiology of ventilator-associated pneumonias. Semin. Respir. Infect. 11:54-61.
4. Brewer, S.C., Wunderink, R.G., Jones, C.B., and Leeper, K.V., Jr. 1996. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest. 109:1019-1029.
5. Craven, D.E., and Steger, K. 1996. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin. Respir. Infect. 11:32-53.
6. Torres, A., et al. 1990. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am. Rev. Respir. Dis. 142:523-528.
7. Parrillo, J.E., et al. 1990 Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann. Intern. Med. 113:227-237.
8. Taylor, G.D., Buchanan-Chell, M., Kirkland, T., McKenzie, M., and Wiens, R. 1994. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest. 108:786-788.
9. Apodaca, G., et al. 1995. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect. Immun. 63:1541-1551.
10. Sawa, T., et al. 1998. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections. Infect. Immun. 65:579-586.
11. Wiener-Kronish, J.P., Sawa, T., Kurahashi, K., Ohara, M., and Gropper, M.A. 1998. Pulmonary edema associated with bacterial pneumonia. In Pulmonary edema. M. Matthay and D. Ingbar, editors. Marcel Dekker Inc. New York, NY. 247-267.
12. Wiener-Kronish, J.P., Albertine, K.H., and Matthay, M.A. 1991. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88:864-875.
13. Wiener-Kronish, J.P., et al. 1993. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J. Appl. Physiol. 75:1661-1669.
14. Kudoh, I., Wiener-Kronish, J.P., Hashimoto, S., Pittet, J.F., and Frank, D. 1994. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. Am. J. Physiol. 267:L551-L556.
15. Sawa, T., et al. 1997. IL-10 improves lung injury and survival in Pseudomonas pneumonia. J. Immunol. 159:2858-2866.
16. Beutler, B., and Cerami, A. 1988. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu. Rev. Biochem. 57:505-518.
17. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
18. Pepe, P.E., Potkin, R.T., Reus, D.H., Hudson, L.D., and Carrico, C.J. 1982. Clinical predictors of the adult respiratory distress syndrome. Am. J. Surg. 144:124-130.
19. Fleiszig, S.M.J., et al. 1997. Cytotoxic and invasive strains of Pseudomonas aeruginosa are genotypically distinct at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.
20. Finck-Barbancon, V., et al. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
21. Yahr, T.L., Vallis, A.J., Hancock, M.K., Barbieri, J.T., and Frank, D.W. 1998. ExoY, a novel adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. USA. 95:13899-13904.
22. Reddel, R.R., et al. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48:1904-1909.
23. Hurn, R.D., et al. 1996. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood. 87:699-705.
24. Espevik, T., and Nissen-Meyer, J. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95:99-105.
25. Kajikawa, O., Goodman, R.B., Johnson, M.C., II, Konishi, K., and Martin, T.R. 1996. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: cytokines that mediate leukocyte recruitment to the lungs. J. Immunol. Methods. 197:19-29.
26. Kajikawa, O., Johnson, M.C., II, Goodman, R.B., Frevert, C.W., and Martin, T.R. 1997. A sensitive immunoassay to detect the α-chemokine GRO in rabbit blood and lung fluids. J. Immunol. Methods. 205:135-143.
27. Martin, T.R., Pistorese, B.P., Chi, E.Y., Goodman, R.B., and Matthay, M.A. 1989. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84:1609-1619.
28. Wiener-Kronish, J.P., Albertine, K.H., and Matthay, M.A. 1991. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88:864-875.
29. Darbonne, W.C., et al. 1991. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 88:1362-1369.
30. Tutor, J.D., et al. 1994. Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am. J. Respir. Crit. Care Med. 149:1107-1111.
31. Pugin, J., Ricou, B., Steinberg, K.P., Suter, P.M., and Martin, T.R. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153:1850-1866.
32. Goodman, R.B., et al. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care. Med. 154:602-611.
33. Pugin, J., Verghese, G., Widmer, M.-C., and Matthay, M.A. 1999. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 27:304-312.
34. Yagupsky, P., and Nolte, F.S. 1990. Quantitative aspects of septicemia. Clin. Microbiol. Rev. 3:269-279.
35. Nelson, S., et al. 1989. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159:189-194.
36. Leturcq, D.J., et al. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98:1533-1538.
37. Sawa, T., et al. 1999. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5:392-398.